Thomas L. Hood

Thomas L. Hood serves as a Contract Specialist at the Naval Medical Research Unit South (N44852), where he plays a critical role in securing scientific and technical capabilities essential to military medical readiness. He manages the full lifecycle of acquisitions for research, development, and diagnostic solutions focused on tropical and infectious diseases, vector-borne threats, and field-deployable laboratory technologies. His portfolio supports the agency’s mission to protect expeditionary forces through applied biomedical research, ensuring timely procurement of specialized equipment, analytical services, and biological research products aligned with DoD operational needs. Hood collaborates with a diverse range of contractors, including research institutions, biotechnology manufacturers, and analytical instrument suppliers, primarily engaged in high-complexity, mission-critical procurements. His contracting patterns reflect a preference for established technical partners with proven expertise in biosafety level 2–3 environments, entomological surveillance systems, and point-of-care diagnostics. While no single contractor dominates his portfolio, he consistently engages vendors with demonstrated capability in rapid prototype development and field-adaptable medical technologies. His set-aside preferences are overwhelmingly oriented toward open competition, with 97.4% of acquisitions conducted without socioeconomic set-asides, reflecting the specialized nature of the technical requirements and the limited pool of qualified vendors. Nevertheless, he maintains a measured commitment to small business participation, with approximately 2.6% of awards structured as total small business set-asides under FAR 19.5, ensuring opportunities for capable small firms in niche scientific domains. Hood’s primary NAICS focus includes 541715 and 541712 for physical and life sciences R&D, 325414 for biological product manufacturing, and 334516 for analytical laboratory instrumentation. He routinely procures custom diagnostic kits, pathogen detection platforms, vector monitoring systems, and field-deployable biosensors, demonstrating deep expertise in the intersection of military medicine, biodefense, and applied laboratory science. His procurement approach prioritizes technical rigor, regulatory compliance, and mission-aligned innovation.